# First Bancorp: financial statements, quarterly

FBNC · Nasdaq · CIK 811589 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fbnc.md) · [Financials](/companies/fbnc/financials.md) · [Filings](/companies/fbnc/filings.md) · [Insiders](/companies/fbnc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fbnc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [39.1](/filings/0000811589-23-000057.md) | [44.1 d](/filings/0000811589-24-000010.md) | [47.3](/filings/0000811589-24-000035.md) | [47.7](/filings/0000811589-24-000055.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [7.8](/filings/0000811589-24-000070.md) | [8.0 d](/filings/0000811589-26-000051.md) | [6.5](/filings/0000811589-25-000024.md) | [8.2](/filings/0000811589-25-000041.md) | [3.9](/filings/0000811589-25-000077.md) | [3.3 d](/filings/0000811589-26-000051.md) | [10.4](/filings/0000811589-26-000073.md) | [11.3](/filings/0000811589-26-000153.md) | [5.6](/filings/0000811589-25-000077.md) | [1.2 d](/filings/0000811589-26-000051.md) | [12.3](/filings/0000811589-26-000073.md) | [12.9](/filings/0000811589-26-000153.md) |
| Net income | $m | [29.9](/filings/0000811589-24-000070.md) | [29.7 d](/filings/0000811589-26-000051.md) | [25.3](/filings/0000811589-25-000024.md) | [28.7](/filings/0000811589-25-000041.md) | [18.7](/filings/0000811589-25-000077.md) | [3.6 d](/filings/0000811589-26-000051.md) | [36.4](/filings/0000811589-26-000073.md) | [38.6](/filings/0000811589-26-000153.md) | [20.4](/filings/0000811589-25-000077.md) | [15.7 d](/filings/0000811589-26-000051.md) | [46.7](/filings/0000811589-26-000073.md) | [50.5](/filings/0000811589-26-000153.md) |
| Diluted EPS | $ per share | [0.73](/filings/0000811589-24-000070.md) | not reported | [0.61](/filings/0000811589-25-000024.md) | [0.70](/filings/0000811589-25-000041.md) | [0.45](/filings/0000811589-25-000077.md) | not reported | [0.88](/filings/0000811589-26-000073.md) | [0.93](/filings/0000811589-26-000153.md) | [0.49](/filings/0000811589-25-000077.md) | not reported | [1.13](/filings/0000811589-26-000073.md) | [1.22](/filings/0000811589-26-000153.md) |
| Basic EPS | $ per share | [0.73](/filings/0000811589-24-000070.md) | not reported | [0.61](/filings/0000811589-25-000024.md) | [0.70](/filings/0000811589-25-000041.md) | [0.45](/filings/0000811589-25-000077.md) | not reported | [0.88](/filings/0000811589-26-000073.md) | [0.93](/filings/0000811589-26-000153.md) | [0.49](/filings/0000811589-25-000077.md) | not reported | [1.13](/filings/0000811589-26-000073.md) | [1.22](/filings/0000811589-26-000153.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [12.0](/filings/0000811589-23-000057.md) | [12.1](/filings/0000811589-25-000008.md) | [12.1](/filings/0000811589-24-000035.md) | [12.1](/filings/0000811589-24-000055.md) | [12.2](/filings/0000811589-24-000070.md) | [12.1](/filings/0000811589-26-000051.md) | [12.4](/filings/0000811589-25-000024.md) | [12.6](/filings/0000811589-25-000041.md) | [12.8](/filings/0000811589-25-000077.md) | [12.7](/filings/0000811589-26-000153.md) | [12.9](/filings/0000811589-26-000073.md) | [13.0](/filings/0000811589-26-000153.md) |
| Total liabilities | $bn | [10.7](/filings/0000811589-23-000057.md) | [10.7](/filings/0000811589-25-000008.md) | [10.7](/filings/0000811589-24-000035.md) | [10.7](/filings/0000811589-24-000055.md) | [10.7](/filings/0000811589-24-000070.md) | [10.7](/filings/0000811589-26-000051.md) | [10.9](/filings/0000811589-25-000024.md) | [11.1](/filings/0000811589-25-000041.md) | [11.1](/filings/0000811589-25-000077.md) | [11.0](/filings/0000811589-26-000153.md) | [11.3](/filings/0000811589-26-000073.md) | [11.3](/filings/0000811589-26-000153.md) |
| Long-term debt | $bn | [0.4](/filings/0000811589-23-000057.md) | [0.6](/filings/0000811589-25-000008.md) | [0.3](/filings/0000811589-24-000035.md) | [0.1](/filings/0000811589-24-000055.md) | [0.1](/filings/0000811589-24-000070.md) | [0.1](/filings/0000811589-26-000051.md) | [0.1](/filings/0000811589-25-000024.md) | [0.1](/filings/0000811589-25-000041.md) | [0.1](/filings/0000811589-25-000077.md) | [0.1](/filings/0000811589-26-000153.md) | [0.1](/filings/0000811589-26-000073.md) | [0.1](/filings/0000811589-26-000153.md) |
| Short-term borrowings | $bn | not reported | [0.5](/filings/0000811589-25-000008.md) | not reported | not reported | not reported | [0.0](/filings/0000811589-26-000051.md) | not reported | not reported | not reported | [0.0](/filings/0000811589-26-000051.md) | not reported | not reported |
| Shareholders' equity | $bn | [1.3](/filings/0000811589-24-000070.md) | [1.4](/filings/0000811589-26-000051.md) | [1.4](/filings/0000811589-25-000041.md) | [1.4](/filings/0000811589-25-000077.md) | [1.5](/filings/0000811589-25-000077.md) | [1.4](/filings/0000811589-26-000153.md) | [1.5](/filings/0000811589-26-000153.md) | [1.6](/filings/0000811589-26-000153.md) | [1.6](/filings/0000811589-25-000077.md) | [1.7](/filings/0000811589-26-000153.md) | [1.7](/filings/0000811589-26-000153.md) | [1.7](/filings/0000811589-26-000153.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [28.1 d](/filings/0000811589-24-000070.md) | [38.2 d](/filings/0000811589-26-000051.md) | [(20.1)](/filings/0000811589-25-000024.md) | [87.7 d](/filings/0000811589-25-000041.md) | [38.4 d](/filings/0000811589-25-000077.md) | [68.7 d](/filings/0000811589-26-000051.md) | [52.6](/filings/0000811589-26-000073.md) | [45.7 d](/filings/0000811589-26-000153.md) | [49.7 d](/filings/0000811589-25-000077.md) | [55.2 d](/filings/0000811589-26-000051.md) | [61.2](/filings/0000811589-26-000073.md) | [66.5 d](/filings/0000811589-26-000153.md) |
| Capital expenditure | $m | [1.3 d](/filings/0000811589-24-000070.md) | [1.2 d](/filings/0000811589-26-000051.md) | [1.6](/filings/0000811589-25-000024.md) | [0.1 d](/filings/0000811589-25-000041.md) | [0.4 d](/filings/0000811589-25-000077.md) | [0.5 d](/filings/0000811589-26-000051.md) | [0.2](/filings/0000811589-26-000073.md) | [1.4 d](/filings/0000811589-26-000153.md) | [1.5 d](/filings/0000811589-25-000077.md) | [1.2 d](/filings/0000811589-26-000051.md) | [1.9](/filings/0000811589-26-000073.md) | [1.0 d](/filings/0000811589-26-000153.md) |
| Dividends paid | $m | [9.0 d](/filings/0000811589-24-000070.md) | [9.0 d](/filings/0000811589-26-000051.md) | [9.0](/filings/0000811589-25-000024.md) | [9.1 d](/filings/0000811589-25-000041.md) | [9.1 d](/filings/0000811589-25-000077.md) | [9.1 d](/filings/0000811589-26-000051.md) | [9.1](/filings/0000811589-26-000073.md) | [9.1 d](/filings/0000811589-26-000153.md) | [9.5 d](/filings/0000811589-25-000077.md) | [9.5 d](/filings/0000811589-26-000051.md) | [9.5](/filings/0000811589-26-000073.md) | [9.9 d](/filings/0000811589-26-000153.md) |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0000811589-25-000024.md) | [0.0 d](/filings/0000811589-25-000041.md) | [0.0 d](/filings/0000811589-25-000077.md) | [0.0 d](/filings/0000811589-26-000051.md) | [1.0](/filings/0000811589-26-000073.md) | [0.0 d](/filings/0000811589-26-000153.md) | [0.0 d](/filings/0000811589-25-000077.md) | [(0.0) d](/filings/0000811589-26-000051.md) | [5.1](/filings/0000811589-26-000073.md) | [2.1 d](/filings/0000811589-26-000153.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [35.7](/filings/0000811589-23-000057.md) | [41.1](/filings/0000811589-24-000035.md) | [41.1](/filings/0000811589-24-000055.md) | [41.2](/filings/0000811589-24-000070.md) | [41.2](/filings/0000811589-25-000024.md) | [41.3](/filings/0000811589-25-000041.md) | [41.4](/filings/0000811589-25-000077.md) | [41.4](/filings/0000811589-26-000073.md) | [41.4](/filings/0000811589-26-000153.md) | [41.5](/filings/0000811589-25-000077.md) | [41.5](/filings/0000811589-26-000073.md) | [41.4](/filings/0000811589-26-000153.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 41,374,221 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000811589-26-000153.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.